Catalina Alarcón de la Lastra Selected Research

dosmalfate

12/2003	A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice.
1/2003	Effects of dosmalfate, a new cytoprotective agent, on acute and chronic trinitrobenzene sulphonic acid-induced colitis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catalina Alarcón de la Lastra Research Topics

Disease

7	Colitis 01/2019 - 01/2003
6	Inflammation (Inflammations) 05/2015 - 01/2003
2	Colonic Neoplasms (Colon Cancer) 01/2013 - 01/2013
2	Neoplasms (Cancer) 01/2013 - 09/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2013 - 09/2008
2	Ulcerative Colitis 03/2007 - 11/2003
2	Stomach Ulcer (Gastric Ulcer) 02/2005 - 05/2002
2	Body Weight (Weight, Body) 12/2003 - 12/2002
2	Wounds and Injuries (Trauma) 06/2002 - 04/2002
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019
1	Carcinogenesis 09/2008
1	Necrosis 03/2007
1	Anemia 12/2002
1	Uremia 10/2002
1	Hemorrhage 10/2002
1	Ulcer 05/2002

Drug/Important Bio-Agent (IBA)

5	Peroxidase (Myeloperoxidase)IBA 05/2015 - 05/2002
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2002 - 04/2002
3	AcidsIBA 06/2007 - 01/2003
3	ProstaglandinsIBA 11/2003 - 04/2002
2	CytokinesIBA 01/2019 - 03/2007
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2013
2	Olive OilIBA 05/2015 - 01/2013
2	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 05/2015 - 01/2013
2	CurcuminIBA 09/2008 - 03/2007
2	Acetic Acid (Vinegar)FDA LinkGeneric 02/2005 - 05/2002
2	dosmalfateIBA 12/2003 - 01/2003
2	FlavonoidsIBA 12/2003 - 01/2003
1	Biological ProductsIBA 01/2019
1	InflammasomesIBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	bergeninIBA 01/2019
1	PolyphenolsIBA 05/2015
1	3,4-dihydroxyphenylglycolIBA 05/2015
1	hydroxytyrosyl acetateIBA 05/2015
1	oleuropeinIBA 01/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2007
1	1,5-dihydroxyisoquinolineIBA 06/2007
1	Niacinamide (Nicotinamide)FDA LinkGeneric 06/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2007
1	p38 Mitogen-Activated Protein KinasesIBA 03/2007
1	NitritesIBA 03/2007
1	Prostaglandins EIBA 02/2005
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2003
1	Drinking WaterIBA 12/2003
1	SodiumIBA 12/2003
1	Dextrans (Dextran)FDA Link 12/2003
1	sym-trinitrobenzeneIBA 11/2003
1	rofecoxib (Vioxx)FDA Link 11/2003
1	AntioxidantsIBA 01/2003
1	ErbB Receptors (EGF Receptor)IBA 01/2003
1	Diosmin (Daflon)IBA 01/2003
1	Dipyrone (Metamizole)IBA 12/2002
1	Diclofenac (SR 38)FDA LinkGeneric 12/2002
1	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2002
1	Piroxicam (Feldene)FDA LinkGeneric 10/2002
1	CreatinineIBA 10/2002
1	Urea (Carbamide)FDA LinkGeneric 10/2002
1	Oxygen (Dioxygen)IBA 06/2002
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2002
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2002
1	Celecoxib (Celebrex)FDA Link 05/2002
1	Omeprazole (Prilosec)FDA LinkGeneric 05/2002
1	Dinoprostone (PGE2)FDA Link 05/2002
1	Proton Pump InhibitorsIBA 05/2002
1	Glutathione (Reduced Glutathione)IBA 04/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2002

Therapy/Procedure

1	Therapeutics 01/2019
1	Drug Therapy (Chemotherapy) 09/2008
1	Chemoprevention 09/2008